Air Emissions Permit Renewal for Apotex Pharmaceutical Plant - Toronto

Official title: Apotex Inc. - Environmental Compliance Approval (air)

Closed Regulations & Permits Environment & Climate Health & Safety
Apotex Inc. wants to renew its air emissions permit for a pharmaceutical manufacturing facility in Toronto. The plant releases nitrogen oxides, methylene chloride, and particulate matter from boilers, heaters, and dust collectors. This renewal would continue allowing the facility to operate with some flexibility in how it manages emissions.

Why This Matters

Live near Garyray Drive in northwest Toronto? This facility releases chemicals into the air you breathe. The permit sets limits on how much pollution is allowed. If you have concerns about air quality in your neighbourhood, this is your chance to weigh in.

What Could Change

If approved, Apotex can continue operating its pharmaceutical plant with flexibility to modify equipment and processes within set limits. The permit includes production caps and an expiry date requiring future renewal. Denial or modification could restrict the facility's operations.

Key Issues

  • Should the air emissions permit be renewed for this pharmaceutical facility?
  • Are the current emission limits adequate to protect local air quality?

How to Participate

  1. Review the proposal details and supporting materials. Some materials may only be available in person - contact the ministry office to request access.